MCCOLLUM JAMES W
SEC CIK 1200889 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | Dir | 10.5K | $740.3K | — | 4 | 2024-03-21 | 2025-11-07 |
Most active insiders at LENZ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Versant Vantage II GP-GP, LLC | 10% | — | $10.35M |
| 2 | Olsson Shawn | Chief Commercial Off | — | $261.0K |
| 3 | Schimmelpennink Evert B. | Pres, CEO, Sec, Dir | $251.4K | — |
| 4 | MCCOLLUM JAMES W | Dir | $239.3K | — |
| 5 | Chevallard Daniel R. | CFO | $114.3K | — |
| 6 | George Jeffrey P. | Dir | $49.9K | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | 2025-11-07 | LENZ | LENZ Therapeutics, Inc. | MCCOLLUM JAMES W | Dir | P - Purchase | $22.79 | +10.5K | 10.5K | New | +$239.3K | |
| I | 2024-05-14 | 2024-05-13 | LENZ | LENZ Therapeutics, Inc. | MCCOLLUM JAMES W | Dir | P - Purchase | $15.99 | +31.3K | 525.6K | +6% | +$501.0K |
| D | 2024-03-25 | 2024-03-21 | LENZ | LENZ Therapeutics, Inc. | MCCOLLUM JAMES W | Dir | A - Grant | $0.00 | +95.0K | 95.0K | New | $0 |
| DMI | 2024-03-25 | 2024-03-21 | LENZ | LENZ Therapeutics, Inc. | MCCOLLUM JAMES W | Dir | A - Grant | $0.5058 | +494.2K | 494.2K | New | +$250.0K |
Purchase Sale Sale after option exercise All abbreviations